| 000 | 01682 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250517053358.0 | ||
| 264 | 0 | _c20161012 | |
| 008 | 201610s 0 0 eng d | ||
| 022 | _a1941-837X | ||
| 024 | 7 |
_a10.3111/13696998.2015.1096274 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMerli, Geno J | |
| 245 | 0 | 0 |
_aCosts of hospital visits among patients with deep vein thrombosis treated with rivaroxaban and LMWH/warfarin. _h[electronic resource] |
| 260 |
_bJournal of medical economics _c2016 |
||
| 300 |
_a84-90 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAge Factors |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAnticoagulants _xeconomics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHeparin, Low-Molecular-Weight _xeconomics |
| 650 | 0 | 4 |
_aHospitalization _xeconomics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInsurance Claim Review |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aResidence Characteristics |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aRivaroxaban _xeconomics |
| 650 | 0 | 4 | _aSex Factors |
| 650 | 0 | 4 | _aSocioeconomic Factors |
| 650 | 0 | 4 |
_aVenous Thrombosis _xdrug therapy |
| 650 | 0 | 4 |
_aWarfarin _xeconomics |
| 700 | 1 | _aHollander, Judd E | |
| 700 | 1 | _aLefebvre, Patrick | |
| 700 | 1 | _aLaliberté, François | |
| 700 | 1 | _aRaut, Monika K | |
| 700 | 1 | _aGermain, Guillaume | |
| 700 | 1 | _aBookhart, Brahim | |
| 700 | 1 | _aPollack, Charles V | |
| 773 | 0 |
_tJournal of medical economics _gvol. 19 _gno. 1 _gp. 84-90 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3111/13696998.2015.1096274 _zAvailable from publisher's website |
| 999 |
_c25280344 _d25280344 |
||